Icotinib plus gemcitabine for metastatic pancreatic cancer: A case report

Figure 1 Contrast-enhanced magnetic resonance imaging of the pancreas. A: Before treatment, a mass was observed (arrow) in the head of pancreas; B: Marked shrinkage of the mass was seen after two treatment cycles; C: Mass size remained stable after four treatment cycles.

Figure 2 Contrast-enhanced magnetic resonance imaging of the liver. A: Before treatment, multiple metastatic nodules (arrows) were observed in the liver at three different levels; B: Marked shrinkage of the nodules was seen after two treatment cycles.

Figure 3 Positron emission tomography-computerized tomography. Masses in the pancreas and liver were observed before treatment.

Figure 4 Cytological examination of the pancreatic mass. Hematoxylin and eosin staining indicated the mass was an adenocarcinoma (magnification × 200).